Perspective Therapeutics, Inc.
CATX
$2.99
-$0.13-4.17%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.28% | 30.14% | -44.36% | -20.87% | -18.20% |
| Total Depreciation and Amortization | 1.33% | 12.15% | 29.55% | 5.73% | 0.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.08% | -80.77% | 590.76% | -5.84% | 37.40% |
| Change in Net Operating Assets | 130.12% | -1,343.96% | -90.58% | 898.47% | 83.04% |
| Cash from Operations | 34.38% | -27.62% | -51.34% | 18.35% | 7.55% |
| Capital Expenditure | -106.98% | -35.13% | -154.77% | -94.15% | 77.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 128.45% | -405.53% | 110.29% | 202.16% | 681.96% |
| Cash from Investing | 113.71% | -483.90% | 103.95% | 228.14% | 176.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 13.33% | -15.38% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -99.90% | -- | -100.00% | 55.86% | -98.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.91% | 1,264,438.46% | -106.10% | 61.36% | -98.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -123.49% | 503.65% | 285.29% | 86.58% | 9.42% |